Position in AZN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$292,204
-$1,851 QoQ
Shares Held
1,541
+3.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,059
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E&G Advisors, LP holds $9,382,400 across 9 Drug Manufacturers - General names. AZN ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,773 | $2,126,589 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
16,647 | $2,103,181 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,325 | $1,840,762 | |
| 4 | ABBV |
AbbVie Inc.
|
3,609 | $908,168 | |
| 5 | NVS |
Novartis AG
|
5,127 | $803,503 | |
| 6 | AMGN |
Amgen Inc
|
2,166 | $784,351 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,541 | $292,204 | |
| 8 | SNY |
Sanofi
|
6,398 | $272,938 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292,204 | 1,541 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $294,055 | 1,491 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||